GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
Quick Stats
Jan 30, 202639.0
AI Score
SELL0.79
Volume Ratio
Next Earnings
11
+ve Days (30d)
18
-ve Days (30d)
GCTK Stock Summary
Last updated Jan 30, 2026
GCTK is currently trading at $1.91, positioned below its 200-day moving average of $5.79, suggesting bearish momentum. The stock has a 52-week range of $0.093 to $127.8.
Technical Analysis: The 50-day moving average stands at $4.56, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 20.202, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.684, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates GCTK at 39.0/100 with a SELL recommendation.
GCTK (GlucoTrack, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 20.202 |
| CMF (20) | -0.684 |
| ROC (10) | -52.01 |
| ADX (14) | 25.229 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.523 |
| AROONOSC (14) | -71.429 |
| WILLAMS %R (14) | -99.573 |
| MFI (14) | 1.608 |
GCTK Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GCTK Price vs Max Options Open Interest
GCTK Max Change In Options Open Interest
GCTK Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GCTK Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GCTK Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GCTK Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GlucoTrack, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
GCTK Moving Averages Analysis
GCTK (GlucoTrack, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 3.33 |
| 20 | 3.58 |
| 30 | 3.83 |
| 50 | 4.56 |
| 100 | 5.57 |
| 200 | 5.79 |
GCTK Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 3.1 million |
| Earnings/Share ($) | -1268.49 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | -- |
| Most Recent Quarter |
GlucoTrack, Inc. (Nasdaq: GCTK) has entered a $20 million stock purchase agreement with Sixth Borough Capital, providing flexible funding for working capital and corporate needs. The company will be participating in the Q3 Virtual Investor Summit on September 16-17, 2025. Investors are anticipating big biopharma news and a potential partnership announcement with Abbott. The company issued a $3.6 million convertible note on September 12, 2025, which has not yet been converted into shares. This is a private transaction with a specific investor.
Updated 2025-09-13 15:00:02